These and other GLP1-RA diabetes/weight-loss meds can also boost outcomes for folks battling chronic kidney disease, new ...

GLP-1 medications are renowned for their ability to treat type 2 diabetes and aid weight loss. Now, there's a new benefit to ...

Ozempic, the blockbuster GLP-1 drug that was originally approved to treat type 2 diabetes, has now also been approved by the US Food and Drug Administration to reduce certain risks associated with ...

Semaglutide reduced the risk of kidney disease worsening, renal failure, and CV death by 24% compared with placebo. The approval was based on data from the randomized, double-blind, placebo-controlled ...

about a third of adults with diabetes also have chronic kidney disease, according to the US Centers for Disease Control and Prevention The clinical trial tested the efficacy of Ozempic when added ...

Semaglutide lowered the risk for kidney disease events by 24% in the FLOW trial. The FDA has approved ... “This new CKD indication for Ozempic is very important, as individuals with CKD are ...

Nephrologists jumped on the GLP-1 bandwagon well before Novo Nordisk won FDA approval for Ozempic in chronic kidney disease ...